Enzalutamide (MDV-3100)
-![C21H16F4N4O2S](http://labshops.com/cdn/shop/products/C-1376_231x231.jpg?v=1559932689)
Technical Data
Description
Enzalutamide (MDV-3100) is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, selective androgen receptor modulator MDV3100 inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level.